Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants

Luger, T., Boguniewicz, M., Carr, W. et al. (22 more authors) (2015) Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants. Pediatric Allergy and Immunology, 26 (4). pp. 306-315. ISSN 0905-6157



  • Luger, T.
  • Boguniewicz, M.
  • Carr, W.
  • Cork, M. ORCID logo https://orcid.org/0000-0003-4428-2428
  • Deleuran, M.
  • Eichenfield, L.
  • Eigenmann, P.
  • Foelster-Holst, R.
  • Gelmetti, C.
  • Gollnick, H.
  • Hamelmann, E.
  • Hebert, A.A.
  • Muraro, A.
  • Oranje, A.P.
  • Paller, A.S.
  • Paul, C.
  • Puig, L.
  • Ring, J.
  • Siegfried, E.
  • Spergel, J.M.
  • Stingl, G.
  • Taieb, A.
  • Torrelo, A.
  • Werfel, T.
  • Wahn, U.
Copyright, Publisher and Additional Information: © 2015 The Authors. Pediatric Allergy and Immunology Published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Keywords: atopic dermatitis; eczema; infants; paediatric; pimecrolimus; safety; tacrolimus; topical calcineurin inhibitors; topical corticosteroids
  • Accepted: 28 December 2014
  • Published: June 2015
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Infection, Immunity and Cardiovascular Disease
The University of Sheffield > Sheffield Teaching Hospitals
Funding Information:
FunderGrant number
Depositing User: Symplectic Sheffield
Date Deposited: 30 Aug 2017 11:24
Last Modified: 30 Aug 2017 11:29
Published Version: https://doi.org/10.1111/pai.12331
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: https://doi.org/10.1111/pai.12331
Related URLs: